223 related articles for article (PubMed ID: 19779119)
1. Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression.
Johnke RM; Edwards JM; Evans MJ; Nangami GN; Bakken NT; Kilburn JM; Lee TK; Allison RR; Karlsson UL; Arastu HH
In Vivo; 2009; 23(5):827-33. PubMed ID: 19779119
[TBL] [Abstract][Full Text] [Related]
2. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression.
Johnke RM; Edwards JM; Kovacs CJ; Evans MJ; Daly BM; Karlsson UL; Lee TK; Allison RR; Arastu HH; Cariveau MJ; O'Brien KF
Anticancer Res; 2005; 25(4):3159-66. PubMed ID: 16080580
[TBL] [Abstract][Full Text] [Related]
3. Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer.
Francini G; Paolelli L; Francini E; Pascucci A; Manganelli A; Salvestrini F; Petrioli R
Eur J Surg Oncol; 2008 Feb; 34(2):216-21. PubMed ID: 17502132
[TBL] [Abstract][Full Text] [Related]
4. Cytokines levels in prostate adenocarcinomas.
Bălăşoiu M; Turculeanu A; Avrămescu C; Comănescu V; Simionescu C; Mogoantă L
Rom J Morphol Embryol; 2005; 46(3):179-82. PubMed ID: 16444302
[TBL] [Abstract][Full Text] [Related]
5. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Oct; 98(4):770-2. PubMed ID: 16879448
[TBL] [Abstract][Full Text] [Related]
6. Circulating Cytokine Levels in Patients with Prostate Cancer: Effects of Neoadjuvant Hormonal Therapy and External-beam Radiotherapy.
Tanji N; Kikugawa T; Ochi T; Taguchi S; Sato H; Sato T; Sugahara T; Hamada H; Asai S; Matsumoto A
Anticancer Res; 2015 Jun; 35(6):3379-83. PubMed ID: 26026098
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate.
Kovacs CJ; Daly BM; Evans MJ; Johnke RM; Lee TK; Karlsson UL; Allison R; Eaves GS; Biggs LM
Cytokine; 2003 Sep; 23(6):151-63. PubMed ID: 12967640
[TBL] [Abstract][Full Text] [Related]
8. Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer.
Castaldo ET; Parikh AA; Pinson CW; Feurer ID; Merchant NB
Arch Surg; 2009 Feb; 144(2):129-34; discussion 134-5. PubMed ID: 19221323
[TBL] [Abstract][Full Text] [Related]
9. Elevation of cytokine levels in cachectic patients with prostate carcinoma.
Pfitzenmaier J; Vessella R; Higano CS; Noteboom JL; Wallace D; Corey E
Cancer; 2003 Mar; 97(5):1211-6. PubMed ID: 12599227
[TBL] [Abstract][Full Text] [Related]
10. How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
Choo R; Chander S; Danjoux C; Morton G; Pearce A; Deboer G; Szumacher E; Loblaw A; Cheung P; Woo T
Can J Urol; 2005 Feb; 12(1):2547-52. PubMed ID: 15777493
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
Premkumar VG; Yuvaraj S; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):387-91. PubMed ID: 17516992
[TBL] [Abstract][Full Text] [Related]
12. [Histological investigation of prostate cancer treated with hormonal agents].
Azumi M; Saga Y; Hashimoto H; Kakizaki H
Hinyokika Kiyo; 2006 Oct; 52(10):781-4. PubMed ID: 17131867
[TBL] [Abstract][Full Text] [Related]
13. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment.
Zhou Q; Zhu XQ; Zhang J; Xu ZL; Lu P; Wu F
Ultrasound Med Biol; 2008 Jan; 34(1):81-7. PubMed ID: 17854983
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.
Christensen E; Pintilie M; Evans KR; Lenarduzzi M; Ménard C; Catton CN; Diamandis EP; Bristow RG
Clin Cancer Res; 2009 Sep; 15(17):5576-83. PubMed ID: 19706801
[TBL] [Abstract][Full Text] [Related]
15. Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.
Khatri A; Husaini Y; Ow K; Chapman J; Russell PJ
Clin Cancer Res; 2009 Apr; 15(7):2323-34. PubMed ID: 19318483
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
Hart JP; Broadwater G; Rabbani Z; Moeller BJ; Clough R; Huang D; Sempowski GA; Dewhirst M; Pizzo SV; Vujaskovic Z; Anscher MS
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1448-54. PubMed ID: 16115739
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and neoadjuvant therapies in high risk localized prostate cancer.
Giannakopoulos X; Stagikas D; Charalabopoulos A; Sofikitis N; Charalabopoulos K
J Exp Clin Cancer Res; 2006 Dec; 25(4):469-73. PubMed ID: 17310835
[TBL] [Abstract][Full Text] [Related]
18. An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology.
Sui W; Tan J; Guo J; Du G; Dai Y
Ren Fail; 2009; 31(1):1-5. PubMed ID: 19142802
[TBL] [Abstract][Full Text] [Related]
19. Cytokine expression profile over time in severely burned pediatric patients.
Finnerty CC; Herndon DN; Przkora R; Pereira CT; Oliveira HM; Queiroz DM; Rocha AM; Jeschke MG
Shock; 2006 Jul; 26(1):13-9. PubMed ID: 16783192
[TBL] [Abstract][Full Text] [Related]
20. Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: a pilot study.
Ahlberg K; Ekman T; Gaston-Johansson F
Biol Res Nurs; 2004 Jan; 5(3):203-10. PubMed ID: 14737921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
